SUMMARY A study of lymphocyte cytotoxicity for rabbit hepatocyte cultures in 15 patients with untreated chronic active hepatitis showed positive results in all cases, both HBsAg positive and negative. After immunosuppressive therapy cytotoxicity became negative and remained negative, in four of nine patients followed serially. In 51 patients established on therapy for periods from three months to 12 years, cytotoxicity was negative in 19 and all patients are currently alive. However, in the remaining 32 patients in whom cytotoxicity was positive there has been a 34% mortality.
in the remaining 32 patients in whom cytotoxicity was positive there has been a 34% mortality.
Cytotoxicity remained persistently positive in 12 of 15 patients followed serially, and persistently negative in seven of nine. Cytotoxicity showed a significant association with histological disease activity, especially the extent of piecemeal necrosis, but not with biochemical tests of liver function, immunoglobulins, or autoantibodies. The basis of this cytotoxicity test is an antibody dependent cell-mediated autoimmune reaction directed against a liver specific protein, and the results suggest that in some cases immunosuppressive therapy is followed by control of this reaction. It may be possible to stop therapy in these patients, but in those in whom the reaction continues, as shown by continuing cytotoxicity, the prognosis is not as good and the use of other drug schedules would seem worthy of trial.
There is now considerable evidence to suggest that cell-mediated autoimmune reactions are involved in the pathogenesis of chronic active hepatitis . Such patients have been shown to be sensitised to a liver specific membrane lipoprotein (LSP) (Miller et al., 1972; Thestrup-Pedersen et al., 1976) , and their lymphocytes to be cytotoxic for autologous liver cells Geubel et al., 1976) , Chang cells Jacques et al., 1976) , and rabbit hepatocytes (Thomson et al., 1974) in tissue culture. In the latter system the reaction can be blocked by LSP, suggesting that it is the major target antigen involved (Thomson et al., 1974) and the ability to demonstrate cytotoxicity after the removal of T cells, and not with 'T cell enriched fractions, suggests that the reaction is mediated by Fc receptor bearing cells and is therefore another example of antibody dependent cellmediated cytotoxicity .
Antibodies reacting with the antigen on the surface Received for publication 8 November 1977 of rabbit hepatocytes have now been demonstrated in the serum of some patients with antigen negative chronic hepatitis (Tage-Jensen et al., 1977) , and repeated immunisation of rabbits with LSP has produced histological changes very similar to chronic aggressive hepatitis (Meyer zum Buschenfelde et al., 1972) .
The improvement in survival time following immunosuppressive therapy has been well demonstrated (Cook et al., 1971; Soloway et al., 1972; Murray-Lyon et al., 1973) and in the present study we report the effects of such treatment on the cytotoxicity of peripheral blood lymphocytes for isolated hepatocytes in relation to biochemical histological features.
Methods

PATIENTS
Sixty-six patients with chronic active hepatitis, diagnosed at the time of presentation according to the criteria of de Groote et al. (1968) (Cochrane et al., 1977) . The morphological appearance of the cells, both on light and electron microscopy, their ability to synthesise albumin and to incorporate 14C leucine into acid precipitable material suggested that they were hepatocytes (Hughes et al., 1976) . Further evidence of their viability has been shown using metabolic inhibitors and a 51Cr release assay (Hughes et al., 1976) . Lymphocytes were prepared from peripheral venous blood by dextran sedimentation, filtration through a cotton wool column (Rocklin et al., 1970) , followed by centrifugation over Ficoll triosil (Boyum, 1968 (Table 1) . Serial cytotoxicity tests were performed in nine of these patients following immunosuppressive therapy. Cytotoxicity became negative in four cases within three to six months ( Fig. 1 ) and has remained negative for up to 22 months. In each case the value of aspartate aminotransferase (AST) has remained below twice normal and repeat liver biopsies were considered to be inactive. In the remaining five cases cytotoxicity remained positive. Three of the patients in this group, with persistently abnormal liver function tests, died in liver failure, two of them two months and one two years after treatment was begun'. The two remaining cases are still alive at 14 months and 24 months, both having AST values twice normal, although they continue to show histtdlogical activity.
Of the 51 patients receiving immunosuppressivetherapy at the time of initial testing, 32 (63%) gave positive and 19 (37%) negative cytotoxicity tests. Eleven (34%) of the 32 patients showing cytotoxicity have so far died, whereas there have been no deaths in those with negative results (X2 = 5 0, p < 0 025). The five year survival (Fig. 2) in patients showing cytdtoxicity on the initial test was 55% compared to 100% for those in whom cytotoxicity was negative.
Comparison of patients with positive and negative cytotoxicity at the time of the first test did not (Fig. 3) , those with positive results showed significantly more piecemeal necrosis (p < 001, Rank sum test), rosette formation, and spotty parenchymal necrosis (p < 0 05, Rank sum test) than those with negative results. There were no other significant differences with respect to other histological features examined.
Serial cytotoxicity tests were performed in 24 treated patients. Of 15 with positive cytotoxicity at the initial test (Fig. 4) , 12 (80%) continued to give positive results following continued therapy, although in two the test became negative on one occasion. In contrast, of the nine patients in whom cytotoxicity fell within the normal range on initial testing (Fig. 5) , only two (22%), both with values close to the upper limit of the normal range, became positive, a significant difference (x2 5-5, p < 0025). showed positive cytotoxicity on first testing (symbols as for Fig. 1 (Gonzalez et al., 1978) Competition for these receptor sites by other immune complexes present in the serum, perhaps as a consequence of the liver damage, will therefore modify the degree of cytotoxicity.
Although in the patients already established on immunosuppressive therapy there was a close association between the ability to demonstrate cytotoxicity and an active liver biopsy (score of 7 or more), there was again no correlation between the degree of cytotoxicity and biopsy score in those showing positive cytotoxicity. As the cytotoxic reaction is thought to be antibody mediated , the striking association between the finding of cytotoxicity and the pressure of piecemeal necrosis may be due to periportal hepatocytes adsorbing the majority of antibody to liverspecific protein, and thus being the most susceptible to destruction by Fc-receptor bearing cells. This may be why periportal or piecemeal necrosis is such a hallmark of this disease in both HBsAg negative and positive cases.
In contrast with the association between positive cytotoxicity and certain histological features there were no significant differences in liver function tests, immunoglobulins, or frequency of autoantibodies between those with and without lymphocyte cytotoxicity. We have suggested that immunoglobulin levels may be largely genetically determined, while autoantibodies may be markers of an inherited autoimmune diathesis (Galbraith et al., 1976) and neither would therefore directly reflect disease activity. As liver function tests reflect the synthetic and metabolic capacity of the liver as a whole and cytotoxicity reflects only one specific immunological reaction, it would be surprising if there were an association between any of these parameters.
The factors determining t-he variability in the response to treatment are largely unknown, but it may be helpful in planning the management of these patients to construct a working hypothesis. Thus, it seems likely that the conventional immunosuppressive drugs in the doses used by most authors are not truly immunosuppressive but are principally exerting an anti-inflammatory action (Denman et al., 1970) . We have proposed that the autoimmune reaction in chronic active hepatitis is maintained by a constant helper T-cell stimulus of autoreactive B cells and a partial defect in suppressor T-cell activity . In HBsAg negative chronic active hepatitis the latter defect would predominate, but Allison et al. (1971) have pointed to the potential importance of altered self antigens, released at the site of tissue *njury, acting to promote a helper T-cell response. Corticosteroids with their action to reduce lysozomal enzyme release would be potent inhibitors of this process, and the reduction in the formation of the altered self antigens could be sufficient to allow a weak suppressor T-cell system to regain control. In HBsAg positive chronic active hepatitis, on the other hanid, the self antigens are altered by viral products and anti-inflammatory drugs would not directly reduce formation, and the stimulus for autoimmunity would persist. This may explain the relatively poor response to treatment in the HBsAg positive cases reported by Schalm et al. (1976) . We found all but one of our antigen positive cases to be histologically active with persistently positive cytotoxicity and half have so far died. In this group, and in the HBsAg negative cases with postulated severe suppressor T-cell defects, more intense therapy with a truly immunosuppressive action might be needed and it is of interest that Schalm was able to establish control in some of his unresponsive cases by doubling the dose of prednisone or azathioprine.
